Evaluating robotic surgery for liver tumor removal
A Study to Evaluate Safety and Feasibility of Robotic Liver Resection
This study is testing if using robotic surgery to remove liver tumors is safer and more effective than traditional surgery methods for patients with liver tumors.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Zhejiang University Academic / other |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06353672 on ClinicalTrials.gov |
What this trial studies
This study evaluates the safety and feasibility of robotic liver resection compared to traditional laparoscopic and open liver surgeries. It utilizes advanced robotic surgical technology to enhance precision and flexibility during liver operations, particularly in complex cases. The aim is to gather reliable data on the benefits of robotic techniques in liver surgery, addressing previous limitations in comparative studies. By focusing on patients diagnosed with liver tumors, the study seeks to provide insights into the effectiveness of robotic interventions.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with a liver tumor who are eligible for robotic liver resection.
Not a fit: Patients undergoing simultaneous malignancy resection of the colorectum or other organs may not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to improved surgical outcomes and recovery for patients undergoing liver tumor removal.
How similar studies have performed: Previous studies have shown limited evidence for improved outcomes with robotic liver resection compared to other surgical methods, indicating this approach is still being explored.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patients were diagnosed with a liver tumor. * The patients underwent robotic liver resection. Exclusion Criteria: * The patients underwent simultaneous malignancy resection of the colorectum or other organs (except gallbladder).
Where this trial is running
Hangzhou, Zhejiang
- First Affiliated Hospital, Medical College of Zhejiang University — Hangzhou, Zhejiang, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.